SCHEMBL19145231

SCHEMBL19145231

CN(C)CCC1CCN(C(=O)CC(CSc2ccccc2)NC(=O)OCc2ccccc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GPR55 Q9Y2T6 2/20 0.42
CASP1 P29466 1/20 0.42
CCR1 P32246 1/20 0.40
CTSK P43235 3/20 0.40
ITGB3 P05106 2/20 0.40
ITGA2B P08514 2/20 0.40
BCHE P06276 2/20 0.40
ACHE P22303 2/20 0.40
CACNA1F O60840 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNA1S Q13698 1/20 0.40
CACNA1C Q13936 1/20 0.40
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19145431 1.00 MEN1 (0.42) MEN1KMT2AGPR55CASP1CCR1
SCHEMBL19145558 0.88 MEN1 (0.44) MEN1KMT2AGPR55CASP1CCR1
SCHEMBL19145111 0.88 MEN1 (0.44) MEN1KMT2AGPR55CASP1CCR1
SCHEMBL19145313 0.88 CTSK (0.43) CCR1CTSKITGB3ITGA2BBCHE
SCHEMBL19145104 0.88 P2RY12 (0.40) MEN1KMT2AITGB3ITGA2BBCHE
SCHEMBL19145314 0.85 MEN1 (0.43) MEN1KMT2AGPR55CASP1CCR1
SCHEMBL19145250 0.85 MEN1 (0.43) MEN1KMT2AGPR55CASP1CCR1
SCHEMBL19145341 0.83 ALDH1A1 (0.45) MEN1KMT2AGPR55CASP1ITGB3
SCHEMBL25087898 0.82 FKBP1A (0.52) MEN1KMT2AGPR55CASP1CTSK
SCHEMBL10058359 0.82 FKBP1A (0.52) MEN1KMT2AGPR55CASP1CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017123616-A1 INHIBITING B-CELL LYMPHOMA 2 (BCL-2) AND RELATED PROTEINS MERRIMACK PHARMACEUTICALS, INC. (US) 2017-07-20 WO disclosed